Chemical Component Summary | |
|---|---|
| Name | META VANADATE |
| Identifiers | [bis(oxidanylidene)vanadio-[[[[bis(oxidanylidene)vanadio-[tris(oxidanylidene)vanadio]-$l^{3}-oxidanyl]-bis(oxidanylidene)vanadio]oxy-bis(oxidanylidene)vanadio]oxy-oxidanylidene-vanadio]-$l^{3}-oxidanyl]-tris(oxidanylidene)vanadium |
| Formula | O19 V7 |
| Molecular Weight | 660.579 |
| Type | NON-POLYMER |
| Isomeric SMILES | O=[V](=O)[O@@]([V](=O)(=O)=O)[V](=O)(=O)O[V](=O)(=O)O[V](=O)O([V](=O)=O)[V](=O)(=O)=O |
| InChI | InChI=1S/19O.7V |
| InChIKey | CTUXFMMCMPZRLK-UHFFFAOYSA-N |
Chemical Details | |
|---|---|
| Formal Charge | 0 |
| Atom Count | 26 |
| Chiral Atom Count | 0 |
| Bond Count | 25 |
| Aromatic Bond Count | 0 |
Drug Info: DrugBank
| DrugBank ID | DB02681? |
|---|---|
| Name | 2,8-bis[oxido(oxo)vanadio]-1,1,1,3,5,5,7,7,9,9,9-undecaoxopentavanadoxane-2,8-diium |
| Groups | experimental |
| Synonyms | 2,8-bis[oxido(oxo)vanadio]-1,1,1,3,5,5,7,7,9,9,9-undecaoxopentavanadoxane-2,8-diium |
Drug Targets
| Name | Target Sequence | Pharmacological Action | Actions |
|---|---|---|---|
| Uridine phosphorylase | MSKSDVFHLGLTKNDLQGATLAIVPGDPDRVEKIAALMDKPVKLAShref... | unknown | |
| Cyclin-dependent kinases regulatory subunit 1 | MSHKQIYYSDKYDDEEFEYRHVMLPKDIAKLVPKTHLMSESEWRNLGVQQ... | unknown |
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
